Recycling between cortisol and cortisone in human splanchnic, subcutaneous adipose, and skeletal muscle tissues in vivo

Diabetes

Volumn 61, Issue 6, 2012, Pages 1357-1364

  Hughes, Katherine A ^a   Manolopoulos, Konstantinos N ^b   Iqbal, Javaid ^a   Cruden, Nicholas L ^a   Stimson, Roland H ^a   Reynolds, Rebecca M ^a   Newby, David E ^a   Andrew, Ruth ^a   Karpe, Fredrik ^b   Walker, Brian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CORTISONE; D2 CORTISONE; D4 CORTISOL; HYDROCORTISONE; OXIDOREDUCTASE; STABLE ISOTOPE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GLYCYRRHIZA; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; HYDROCORTISONE RELEASE; LIVER; MALE; PRIORITY JOURNAL; SKELETAL MUSCLE; SPLANCHNIC NERVE; SUBCUTANEOUS FAT; TISSUE METABOLISM;

ADULT; CORTISONE; HUMANS; HYDROCORTISONE; LIVER; MALE; MUSCLE, SKELETAL; SPLANCHNIC CIRCULATION; SUBCUTANEOUS FAT;

EID: 84861870589     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1345     Document Type: Article

References (50)

1. Seckl JR, Walker BR. Minireview: 11beta-hydroxysteroid dehydrogenase type 1 - a tissue-specific amplifier of glucocorticoid action. Endocrinology 2001;142:1371-1376 (Pubitemid 32299662)
2. Andrew R, Smith K, Jones GC, Walker BR. Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol. J Clin Endocrinol Metab 2002;87:277-285 (Pubitemid 34084702)
3. Basu R, Basu A, Grudzien M, et al. Liver is the site of splanchnic cortisol production in obese nondiabetic humans. Diabetes 2009;58:39-45
4. Stimson RH, Andersson J, Andrew R, et al. Cortisol release from adipose tissue by 11beta-hydroxysteroid dehydrogenase type 1 in humans. Diabetes 2009;58:46-53
5. White PC, Rogoff D, McMillan DR, Lavery GG. Hexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolism. Mol Cell Endocrinol 2007;265-266:89-92 (Pubitemid 46273968)
6. Stimson RH, Andrew R, McAvoy NC, Tripathi D, Hayes PC, Walker BR. Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition. Diabetes 2011;60:720-725
7. Rask E, Olsson T, Söderberg S, et al. Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 2001;86: 1418-1421 (Pubitemid 32323037)
8. Walker BR, Connacher AA, Lindsay RM, Webb DJ, Edwards CR. Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. J Clin Endocrinol Metab 1995;80:3155-3159
9. Hughes KA, Webster SP, Walker BR. 11-Beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) inhibitors in type 2 diabetes mellitus and obesity. Expert Opin Investig Drugs 2008;17:481-496 (Pubitemid 351578167)
10. Feig PU, Shah S, Hermanowski-Vosatka A, et al. Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome. Diabetes Obes Metab 2011;13:498-504
11. Rosenstock J, Banarer S, Fonseca VA, et al.; INCB13739-202 Principal Investigators. The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy. Diabetes Care 2010;33: 1516-1522
12. Lavery GG, Walker EA, Draper N, et al. Hexose-6-phosphate dehydrogenase knock-out mice lack 11 beta-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. J Biol Chem 2006;281:6546-6551 (Pubitemid 43847588)
13. Bujalska IJ, Walker EA, Hewison M, Stewart PM. A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells. J Clin Endocrinol Metab 2002;87:1205-1210 (Pubitemid 36121089)
14. Wake DJ, Homer NZM, Andrew R, Walker BR. Acute in vivo regulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by insulin and intralipid infusions in humans. J Clin Endocrinol Metab 2006;91:4682-4688 (Pubitemid 44833457)
15. Wake DJ, Rask E, Livingstone DEW, Söderberg S, Olsson T, Walker BR. Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J Clin Endocrinol Metab 2003;88:3983-3988 (Pubitemid 37034555)
16. Kershaw EE, Morton NM, Dhillon H, Ramage L, Seckl JR, Flier JS. Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes 2005;54:1023-1031 (Pubitemid 40446315)
17. Jang C, Obeyesekere VR, Dilley RJ, Alford FP, Inder WJ. 11Beta hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle. Clin Endocrinol (Oxf) 2006;65:800-805 (Pubitemid 44772361)
18. Basu R, Singh RJ, Basu A, et al. Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11beta-hsd) type 1 pathway. Diabetes 2004;53:2051-2059 (Pubitemid 38970754)
19. Livingstone DE, Jones GC, Smith K, et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000;141:560-563 (Pubitemid 32250479)
20. Katz JR, Mohamed-Ali V, Wood PJ, Yudkin JS, Coppack SW. An in vivo study of the cortisol-cortisone shuttle in subcutaneous abdominal adipose tissue. Clin Endocrinol (Oxf) 1999;50:63-68 (Pubitemid 29079369)
21. Basu R, Singh RJ, Basu A, et al. Obesity and type 2 diabetes do not alter splanchnic cortisol production in humans. J Clin Endocrinol Metab 2005; 90:3919-3926 (Pubitemid 41058152)
22. Jang C, Obeyesekere VR, Dilley RJ, Krozowski Z, Inder WJ, Alford FP. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes. J Clin Endocrinol Metab 2007;92:3314-3320 (Pubitemid 47236407)
23. Abdallah BM, Beck-Nielsen H, Gaster M. Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes. Eur J Clin Invest 2005;35:627-634 (Pubitemid 41406727)
24. Webster SP, Ward P, Binnie M, et al. Discovery and biological evaluation of adamantyl amide 11beta-HSD1 inhibitors. Bioorg Med Chem Lett 2007;17: 2838-2843 (Pubitemid 46636244)
25. Frayn KN, Coppack SW, Humphreys SM, Whyte PL. Metabolic characteristics of human adipose tissue in vivo. Clin Sci (Lond) 1989;76:509-516 (Pubitemid 19116598)
26. Butler PC, Home PD. The measurement of metabolite exchange across muscle beds. Baillieres Clin Endocrinol Metab 1987;1:863-878 (Pubitemid 18079290)
27. Roddie IC, Shepherd JT, Whelan RF. Evidence from venous oxygen saturation measurements that the increase in forearm blood flow during body heating is confined to the skin. J Physiol 1956;134:444-450
28. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D. Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 1995;25:918-923
29. Larsen OA, Lassen NA, Quaade F. Blood flow through human adipose tissue determined with radioactive xenon. Acta Physiol Scand 1966;66:337-345
30. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987;2:821-824
31. Whitworth JA, Stewart PM, Burt D, Atherden SM, Edwards CR. The kidney is the major site of cortisone production in man. Clin Endocrinol (Oxf) 1989;31:355-361 (Pubitemid 19219243)
32. Sahni-Arya B, Flynn MJ, Bergeron L, et al. Cofactor-specific modulation of 11beta-hydroxysteroid dehydrogenase 1 inhibitor potency. Biochim Biophys Acta 2007;1774:1184-1191
33. Best R, Walker BR. Additional value of measurement of urinary cortisone and unconjugated cortisol metabolites in assessing the activity of 11 beta-hydroxysteroid dehydrogenase in vivo. Clin Endocrinol (Oxf) 1997;47:231-236 (Pubitemid 27359904)
34. Palermo M, Shackleton CH, Mantero F, Stewart PM. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf) 1996;45:605-611 (Pubitemid 26411362)
35. Hellman L, Nakada F, Zumoff B, Fukushima D, Bradlow HL, Gallagher TF. Renal capture and oxidation of cortisol in man. J Clin Endocrinol Metab 1971;33:52-62
36. Kasuya Y, Yokokawa A, Takashima S, Shibasaki H, Furuta T. Use of 11alpha-deuterium labeled cortisol as a tracer for assessing reduced 11beta-HSD2 activity in vivo following glycyrrhetinic acid ingestion in a human subject. Steroids 2005;70:117-125 (Pubitemid 41556691)
37. Vierhapper H, Heinze G, Nowotny P. Sex-specific difference in the interconversion of cortisol and cortisone in men and women. Obesity (Silver Spring) 2007;15:820-824 (Pubitemid 46740955)
38. Peterson RE, Pierce CE, Wyngaarden JB, Bunim JJ, Brodie BB. The physiological disposition and metabolic fate of cortisone in man. J Clin Invest 1957;36:1301-1312
39. Andrew R, Westerbacka J, Wahren J, Yki-Järvinen H, Walker BR. The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans. Diabetes 2005;54:1364-1370 (Pubitemid 40586665)
40. Ricketts ML, Verhaeg JM, Bujalska I, Howie AJ, Rainey WE, Stewart PM. Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab 1998;83:1325-1335 (Pubitemid 28496416)
41. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect "Cushing's disease of the omentum"? Lancet 1997;349:1210-1213 (Pubitemid 27190044)
42. Veilleux A, Laberge PY, Morency J, Noël S, Luu-The V, Tchernof A. Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue. J Steroid Biochem Mol Biol 2010;122:28-34
43. Lee M-J, Fried SK, Mundt SS, et al. Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue. Obesity (Silver Spring) 2008;16:1178-1185 (Pubitemid 351770504)
44. Hirasawa G, Sasano H, Takahashi K, et al. Colocalization of 11 beta-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human epithelia. J Clin Endocrinol Metab 1997;82:3859-3863 (Pubitemid 27509383)
45. Hughes KA, Reynolds RM, Andrew R, Critchley HOD, Walker BR. Glucocorticoids turn over slowly in human adipose tissue in vivo. J Clin Endocrinol Metab 2010;95:4696-4702
46. Engeli S, Böhnke J, Feldpausch M, et al. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res 2004;12:9-17 (Pubitemid 41137482)
47. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-2170 (Pubitemid 33150673)
48. Asmal AC, Butterfield WJ, Collins KJ, Few JD. Arteriovenous studies on the uptake and metabolism of cortisol in human forearm. Clin Sci Mol Med 1974;47:345-358
49. van Uum SHM, Hermus ARMM, Sweep CGJ, et al. Short-term cortisol infusion in the brachial artery, with and without inhibiting 11 beta-hydroxysteroid dehydrogenase, does not alter forearm vascular resistance in normotensive and hypertensive subjects. Eur J Clin Invest 2002;32:874-881 (Pubitemid 35478058)
50. Whorwood CB, Donovan SJ, Wood PJ, Phillips DI. Regulation of glucocorticoid receptor alpha and beta isoforms and type I 11beta-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance? J Clin Endocrinol Metab 2001;86:2296-2308 (Pubitemid 32472955)